News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Macrogen-AseBio-biotecnologia
Macrogen becomes the first company to bring NovaSeq X Plus to Korea, the first in Asia
Access to innovation · Corporate
Macrogen, a global company specializing in genome sequencing, completed the installation of…
Partners - MACROGEN SPAIN
Almirall-AseBio-Biotecnologia-Centro
Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis
Healthcare · Access to innovation
Almirall recently announced the publication of Week 16 and Week 52 results of ADvocate1 and…
Partners - Almirall
Biolan-AseBio-Biotecnología
BIOLAN participates in the PESCAZUL project, in search of a more sustainable and resilient strategy for the fisheries sector
Corporate
PESCAZUL is a project that seeks to promote an analysis of the Spanish fisheries and aquaculture…
Partners - Biolan
oryzon-foto-noticia
ORYZON announces positive results from planned interim analysis of PORTICO, a Phase 2b adaptive trial in Borderline Personality Disorder
Healthcare
Based on interim efficacy and safety data, Independent Data Monitoring Committee recommends…
Partners - Oryzon Genomics
Firma cátedra Peaches UAM
Peaches Biotech, the Universidad Autónoma of Madrid (UAM) and its Foundation create the first University Chair in Advanced Therapies based on cell secretomes 
Personalized medicine · Advanced therapies
The UAM-Peaches Chair will promote research and teaching in the areas of Cellular Therapy and…
Partners - PEACHES BIOTECH S.L.
3p-AseBio-Biotecnologia.
The Regional Minister for Economic and Business Development Mikel Irujo meets with the management of 3P Biopharmaceuticals and its majority shareholder Keensight Capital
Access to innovation · Corporate
During the meeting, attendees evaluated 3P's trajectory and its investment plan for the next 5…
Partners - 3PBIOVIAN
Pacto climático Comisión Europea Asebio MNCN Biodiversidad
European Climate Pact shows 100 students how science is protecting the planet
Climate change
AseBio and the National Museum of Natural Sciences are collaborating again to bring biotechnology…
Intein Splicing
Canadian Intelectual Property Office (CIPO) has conceded ZIP Solutions “Split Inteins and uses thereof” patent.
Healthcare · Access to innovation · In vitro diagnostics · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine · Advanced therapies · Gene editing · International
The tool has many biotech applications
Partners - Biotechnology Assets
genesis-AseBio-Biotecnologia
The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages
Access to innovation
The creation of the company has been carried out within the framework of a project supported by EIT…
Partners - GENESIS Biomed